Bioventus Inc (BVS): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Bioventus Inc (BVS) following the 2026 Q1 hedge fund 13F filings?

As of today, BVS has moved -18.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to nan% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), BVS gained -5.8% vs nan% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Bioventus Inc (BVS)

155 + Investors. Track Smart Money conviction in BVS. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — BVS

Based on 155 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added BVS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

155 hedge funds hold BVS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +8% more funds vs a year ago

fund count last 6Q

+11 new funds entered over the past year (+8% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟡

Slight buying edge — 57% buying

87 buying65 selling

Last quarter: 87 funds bought or added vs 65 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~28 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 20 → 26 → 28 → 28. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 28% medium ■ 29% new

67 out of 155 hedge funds have held BVS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +24% but shares only +2% — price-driven

Value

+23%

+2%

Last quarter: the total dollar value of institutional holdings rose +24%, but actual share count only changed +2%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

20 → 20 → 26 → 28 → 28 new funds/Q

New funds entering each quarter: 20 → 26 → 28 → 28. A growing number of institutions are discovering BVS each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 51% veterans vs 33% newcomers

■ 51% veterans ■ 16% 1-2yr ■ 33% new

Entry-cohort mix of 158 holders: 81 (51%) are 2+ year veterans, 25 entered 1–2 years ago, and 52 (33%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

📋

Smaller funds dominant — 15% AUM from top-100

15% from top-100 AUM funds

40 of 155 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

3.9

out of 10

Low Exit Risk

Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	155	146	6.16%
13F Shares	51M	50M	1.99%
Total Value	$462M	$373M	23.83%
New Positions	28	28	-
Increased Positions	58	58	-
Closed Positions	19	15	+4
Reduced Positions	45	38	+7
Total Calls	2	2	-
Total Puts	1	0	100%
PUT/CALL Ratio	0.5	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

155

146

6.16%

13F Shares

51M

50M

1.99%

Total Value

$462M

$373M

23.83%

New Positions

Increased Positions

Closed Positions

Reduced Positions

Total Calls

Total Puts

100%

PUT/CALL Ratio

0.5

0.0

Bullish

Institutional Holders (2026 Q1)

155 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BVS. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 BVS holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Essex Woodlands Management, Inc.	47.45%	13,021,324	$118.9M
2	Juniper Investment Company, LLC	20.22%	6,939,357	$63.4M
3	Nantahala Capital Management, LLC	2.06%	6,122,403	$55.9M
4	Anderson Financial Strategies, LLC	1.02%	172,900	$1.8M
5	Essex Investment Management Co LLC	0.87%	603,258	$5.5M
6	Meros Investment Management, LP	0.82%	207,720	$1.9M
7	Diker Management LLC	0.61%	75,136	$686K
8	Buckley Capital Advisors, LLC	0.54%	81,798	$747K
9	Engine Capital Management, LP	0.35%	315,018	$2.9M
10	VARCOV Co.	0.20%	57,576	$526K
11	Globeflex Capital L P	0.17%	123,052	$1.1M
12	Oberweis Asset Management Inc/	0.17%	628,114	$5.7M
13	Hillsdale Investment Management Inc.	0.17%	671,139	$6.1M
14	Legato Capital Management LLC	0.17%	200,336	$1.8M
15	nVerses Capital, LLC	0.15%	18,484	$169K
16	Knights of Columbus Asset Advisors LLC	0.15%	288,738	$2.6M
17	Royce & Associates LP	0.14%	1,541,282	$14.1M
18	Inspire Investing, LLC	0.14%	182,918	$1.7M
19	Kennedy Capital Management LLC	0.09%	474,971	$4.3M
20	Eversept Partners, LP	0.08%	159,110	$1.5M
21	EntryPoint Capital, LLC	0.06%	23,428	$214K
22	Tocqueville Asset Management L.P.	0.05%	345,000	$3.1M
23	Empirical Asset Management, LLC	0.04%	17,608	$161K
24	Wedge Capital Management L L P/Nc	0.04%	241,826	$2.2M
25	State of Wyoming	0.04%	35,530	$324K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Bioventus Inc (BVS)

What does the Smart Money Trend signal show for BVS?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added BVS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for BVS?

Slight buying edge — 57% buying: Last quarter: 87 funds bought or added vs 65 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for BVS holders?

Smaller funds dominant — 15% AUM from top-100: 40 of 155 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held BVS?

43% of holders stayed for 2+ years: 67 out of 155 hedge funds have held BVS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Bioventus Inc (BVS) following the 2026 Q1 hedge fund 13F filings?

As of today, BVS has moved -18.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to nan% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), BVS has gained -5.8% vs nan% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Bioventus Inc (BVS)

Smart Money Signals — BVS

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Steady growth — +8% more funds vs a year ago

Slight buying edge — 57% buying

Steady new buyers — ~28 new funds per quarter

43% of holders stayed for 2+ years

Value +24% but shares only +2% — price-driven

Growing discovery — still being found

Veteran-anchored — 51% veterans vs 33% newcomers

Smaller funds dominant — 15% AUM from top-100

Institutional Sentiment Summary — BVS

Hedge Fund Ownership: BVS

Market Analysis: BVS

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: BVS

Is It Too Late to Buy Bioventus Inc (BVS) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: BVS

Statistics: BVS

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Bioventus Inc (BVS)

Welcome to 13Foresight!